The Study of Intraperitoneal Docetaxel Plus S-1 for Malignant Ascites
NCT02779608
·
clinicaltrials.gov ↗
PHASE2
Phase
UNKNOWN
Status
50
Enrollment
OTHER
Sponsor class
Conditions
Stomach Neoplasms
Peritoneal Metastasis
Interventions
DRUG:
intraperitoneal docetaxel
DRUG:
oral S-1
Sponsor
Fudan University